Current vascular pharmacology

Keyphrases

Publications

2024

Antonis A Manolis, Theodora A Manolis, Antonis S Manolis
Current Strategies for Atrial Fibrillation Prevention and Management: Taming the Commonest Cardiac Arrhythmia. Current vascular pharmacology (2024)
Ersin Saricam, Arslan Öcal, Murat Doğan Iscanlı, Engin Bozkurt, Erdogan Ilkay, Ömer Faruk Cantekin
Comparison of Amiodarone Loading Dosage in the Treatment of Postoperative Atrial Fibrillation: High Versus Standard Dose Treatment. Current vascular pharmacology (2024)
Sanja Borozan, Snežana Vujošević, Dimitri P Mikhailidis, Emir Muzurović
Metabolic Dysfunction-Associated Steatohepatitis and Cardiovascular Disease Prevention: Is Resmetirom Useful? Current vascular pharmacology (2024)
Zongtao Wang, Zhixin Xie, Tudi Li, Rong Chen, Zhihuan Zeng, Jun Guo
Energy Metabolism Dysregulation in Myocardial Infarction: An Integrative Analysis of Ischemic Cardiomyopathy. Current vascular pharmacology (2024)
Paraskevi Tsiantoula, Vasileios Papaioannou, Nikolaos-Nektarios Giannakopoulos, Theofanis T Papas
Statins, Venous Thromboembolism and Cardiovascular Events. Current vascular pharmacology (2024)
Christina Antza, Victoria Potoupni, Evangelos Akrivos, Stella Stabouli, Vasilios Kotsis
Assessment of Early Vascular Aging Ambulatory Score (EVAAs): A Large Population-based External Validation Study. Current vascular pharmacology (2024)
Duan Liu, Yexiang Jing, Guiyan Peng, Litai Wei, Liang Zheng, Guangqi Chang, Mian Wang
MiR-199a-5p Deficiency Promotes Artery Restenosis in Peripheral Artery Disease by Regulating ASMCs Function via Targeting HIF-1α and E2F3. Current vascular pharmacology (2024)
Kevins Jara-Medina, Luis Lillo, Constanza Lagunas, Gerardo Cabello-Guzmán, Francisco J Valenzuela-Melgarejo
Identification of Vascular Genes Differentially Expressed in the Brain of Patients with Alzheimer's Disease. Current vascular pharmacology (2024)
Fahime Shokrollahi, Ali Pazoki, Abbas Allami, Shahin Aliakbari, Kimia Rahimi Ardali
Bosentan and Pulmonary Hypertension Caused by COVID-19: A Pilot Randomized Double-blind Clinical Study. Current vascular pharmacology (2024)
Jiunn Jye Tan, Dharmani Devi Murugan, Wei Chih Ling, Siew-Keah Lee, Waye Hann Kang
Chronic Administration of Red Yeast Rice Mitigates Endothelial Dysfunction in Spontaneously Hypertensive Rats by Inhibiting Oxidative Stress and Endothelial Nitric Oxide Synthase Uncoupling. Current vascular pharmacology (2024)
Xia Li, Wenhang Zhou, Dianxuan Guo, Youdong Hu, Hualan Zhou, Ying Chen
Roles of MDA-LDL/OX-LDL/LOX-1 and TNF-α/TLR4/NF-κB Signaling Pathways in Myocardial Damage by Implantations of Cardiac Pacemakers in Elderly Patients. Current vascular pharmacology (2024)
Yuehuan Wang, Yi Yang, Yanjuan Song
Cardioprotective Effects of Exercise: The Role of Irisin and Exosome. Current vascular pharmacology (2024)
Arkadiusz Migdalski, Arkadiusz Jawien
Neovascularization as a Leading Mechanism of Intraplaque Hemorrhage and Carotid Plaque Destabilization: A Narrative Review. Current vascular pharmacology (2024)
Laura-Dorina Dinu, Florentina Gatea, Florentina Matei, Cristian Banciu, Emanuel Vamanu
Gut Microbiota Modulation by Selenium and Zinc Enrichment Postbiotic on Dysbiosis Associated with Hypertension. Current vascular pharmacology (2024)
Rohit Kumar Upadhyay, Kuldeep Kumar, Vishal Kumar Vishwakarma, Nirmal Singh, Rajeev Narang, Neeraj Parakh, Mayank Yadav, Sangeeta Yadav, Sachin Kumar, Ahsas Goyal, Harlokesh Narayan Yadav
Delineating the NOX-Mediated Promising Therapeutic Strategies for the Management of Various Cardiovascular Disorders: A Comprehensive Review. Current vascular pharmacology (2024)
Pavel Poredos, Debabrata Mukherjee, Ales Blinc
Statins and Venous Thromboembolic Disease - Where are we Now? Current vascular pharmacology (2024)
Andrew Callan, Sonal Jha, Laura Valdez, Andrew Tsin
Cellular and Molecular Mechanisms of Neuronal Degeneration in Early-Stage Diabetic Retinopathy. Current vascular pharmacology (2024)
Panagiotis Anagnostis, Dimitri P Mikhailidis, Ales Blinc, Mojca Jensterle, Mateja K Ježovnik, Gerit Holger Schernthaner, Pier Luigi Antignani, Katica Bajuk Studen, Miso Sabovic, Pavel Poredos
Peripheral Arterial Disease: An Underestimated Aspect of Menopause-related Cardiovascular Disease. Current vascular pharmacology (2024)
María Fernanda Castillo, Daniela Salgado-Canales, Marco Arrese, Francisco Barrera, Dimitri P Mikhailidis
Effect of Intermittent Fasting on Lipid Profile, Anthropometric and Hepatic Markers in Non-Alcoholic Fatty Liver Disease (NAFLD): A Systematic Review. Current vascular pharmacology (2024)
Mais N Alqasrawi, Zeina N Al-Mahayri, Hiba Alblooshi, Habiba Alsafar, Bassam R Ali
Utilizing Pharmacogenomic Data for a Safer Use of Statins among the Emirati Population. Current vascular pharmacology (2024)
Chang Liu, Dan Liang
Association between Dietary Vitamin E Intake and the Risk of Hypertension in US Adults. Current vascular pharmacology (2024)
Ozge Telci Caklili, Manfredi Rizzo, Mustafa Cesur
Efficacy and Safety of Bempedoic Acid in Patients with High Cardiovascular Risk: An Update. Current vascular pharmacology (2024)
Panagiotis Anagnostis, Dimitri P Mikhailidis, Ales Blinc, Mojca Jensterle, Mateja K Ježovnik, Gerit Holger Schernthaner, Pier Luigi Antignani, Katica Bajuk Studen, Miso Sabovic, Pavel Poredos
Peripheral Arterial Disease: An Underestimated Aspect of Menopause-related Cardiovascular Disease. Current vascular pharmacology (2024)
Mais N Alqasrawi, Zeina N Al-Mahayri, Hiba Alblooshi, Habiba Alsafar, Bassam R Ali
Utilizing Pharmacogenomic Data for a Safer Use of Statins among the Emirati Population. Current vascular pharmacology (2024)
Jing Zhou, Chao-Ke Tang
Cytoplasmic Polyadenylation Element Binding Protein 1 and Atherosclerosis: Prospective Target and New Insights. Current vascular pharmacology (2024)
Nurdan Yilmaz, Yasar Gokhan Gul, Murat Uğurlucan
Sedation with Ketamine-Propofol in Patients Undergoing Transcatheter Aortic Valve Implantation: A Comparative Retrospective Study on General Anesthesia. Current vascular pharmacology (2024)
Monica Verdoia, Matteo Nardin, Rocco Gioscia, Andrea Rognoni, Giuseppe De Luca
Antiplatelet Effect of Low-Dose Prasugrel in Elderly Patients Undergoing Percutaneous Coronary Interventions. Current vascular pharmacology (2024)
Maryam Mahjoubin-Tehran, Raul D Santos, Wael Almahmeed, Khalid Al-Rasadi, Amirhossein Sahebkar
Identification of Critical Genes Differentiating Stable and Unstable Atherosclerotic Plaques: A Bioinformatic and Computational Analysis. Current vascular pharmacology (2024)
Xia Li, Wenhang Zhou, Dianxuan Guo, Youdong Hu, Hualan Zhou, Ying Chen
Cardiac Radiofrequency Ablation Exacerbates Myocardial Injury through Pro-Inflammatory Response and Pro-Oxidative Stress in Elderly Patients with Persistent Atrial Fibrillation. Current vascular pharmacology (2024)
Saeed Abughazaleh, Omar Obeidat, Mohammad Tarawneh, Hashim Al-Ani, Ahmad Al Nawaiseh, Mohamed F Ismail
Burden of Ischemic Heart Diseases among US States from 1990-2019. Current vascular pharmacology (2024)
Pier Luigi Antignani, Mateja K Jezovnik, Ales Blinc, Dimitri P Mikhailidis, Panagiotis Anagnostis, Gerit Holger Schernthaner, Mojca Jensterle, Katica Bajuk Studen, Miso Sabovic, Pavel Poredos
Hyperparathyroidism and Peripheral Arterial Disease. Current vascular pharmacology (2024)
Pier Luigi Antignani, Mateja K Jezovnik, Ales Blinc, Dimitri P Mikhailidis, Panagiotis Anagnostis, Gerit Holger Schernthaner, Mojca Jensterle, Katica Bajuk Studen, Miso Sabovic, Pavel Poredos
Hyperparathyroidism and Peripheral Arterial Disease. Current vascular pharmacology (2024)

volume 22, number 2, 2024

Pier Luigi Antignani, Mateja K Jezovnik, Ales Blinc, Dimitri P Mikhailidis, Panagiotis Anagnostis, Gerit-Holger Schernthaner, Mojca Jensterle, Katica Bajuk Studen, Miso Sabovic, Pavel Poredos
Hyperparathyroidism and Peripheral Arterial Disease. Current vascular pharmacology 22 (2) (2024)
Jing Zhou, Chao-Ke Tang
Cytoplasmic Polyadenylation Element Binding Protein 1 and Atherosclerosis: Prospective Target and New Insights. Current vascular pharmacology 22 (2) (2024)
Xia Li, Wenhang Zhou, Dianxuan Guo, Youdong Hu, Hualan Zhou, Ying Chen
Cardiac Radiofrequency Ablation Exacerbates Myocardial Injury through Pro-Inflammatory Response and Pro-Oxidative Stress in Elderly Patients with Persistent Atrial Fibrillation. Current vascular pharmacology 22 (2) (2024)
Panagiotis Anagnostis, Dimitri P Mikhailidis, Ales Blinc, Mojca Jensterle, Mateja K Ježovnik, Gerit-Holger Schernthaner, Pier Luigi Antignani, Katica Bajuk Studen, Miso Sabovic, Pavel Poredos
Peripheral Arterial Disease: An Underestimated Aspect of Menopause-related Cardiovascular Disease. Current vascular pharmacology 22 (2) (2024)
Pier Luigi Antignani, Mateja K Jezovnik, Ales Blinc, Dimitri P Mikhailidis, Panagiotis Anagnostis, Gerit-Holger Schernthaner, Mojca Jensterle, Katica Bajuk Studen, Miso Sabovic, Pavel Poredos
Hyperparathyroidism and Peripheral Arterial Disease. Current vascular pharmacology 22 (2) (2024)
Jing Zhou, Chao-Ke Tang
Cytoplasmic Polyadenylation Element Binding Protein 1 and Atherosclerosis: Prospective Target and New Insights. Current vascular pharmacology 22 (2) (2024)

volume 22, number 3, 2024

Renata Trabach Santos, Maria Eduarda de Sá Freire Onofre, Dayene de Assis Fernandes Caldeira, Adriane Bello Klein, Patricia Rieken Macêdo Rocco, Fernanda Ferreira Cruz, Pedro Leme Silva
Pharmacological Agents and Potential New Therapies in Pulmonary Arterial Hypertension. Current vascular pharmacology 22 (3) (2024)
Wei Zuo, Liang Wang, Ran Tian, Lun Wang, Yifan Liu, Hao Qian, Xinglin Yang, Zhenyu Liu
Dapagliflozin Alleviates Myocardial Ischaemia Reperfusion Injury by Activating Mitophagy via the AMPK-PINK1/Parkin Signalling Pathway. Current vascular pharmacology 22 (3) (2024)
Mais N Alqasrawi, Zeina N Al-Mahayri, Hiba Alblooshi, Habiba Alsafar, Bassam R Ali
Utilizing Pharmacogenomic Data for a Safer Use of Statins among the Emirati Population. Current vascular pharmacology 22 (3) (2024)
María Fernanda Castillo, Daniela Salgado-Canales, Marco Arrese, Francisco Barrera, Dimitri P Mikhailidis
Effect of Intermittent Fasting on Lipid Profile, Anthropometric and Hepatic Markers in Non-Alcoholic Fatty Liver Disease (NAFLD): A Systematic Review. Current vascular pharmacology 22 (3) (2024)
Goran Koracevic, Milovan Stojanovic, Marija Zdravkovic, Dragan Lovic, Dragan Simic, Katarina Mladenovic
Proposal of a Modified Classification of Hypertensive Crises: Urgency, Impending Emergency, and Emergency. Current vascular pharmacology 22 (3) (2024)
Debabrata Mukherjee, Steven E Nissen
Lipoprotein (a) as a Biomarker for Cardiovascular Diseases and Potential New Therapies to Mitigate Risk. Current vascular pharmacology 22 (3) (2024)

volume 22, number 4, 2024

Andrea Da Porto, Luca Bulfone, Leonardo Sechi
Antihypertensive Effects of SGLT2-Inhibitors: Considerations for Clinical Practice. Current vascular pharmacology 22 (4) (2024)

2023

Rose Mary Lisboa da Silva, Lucas Espindula Borges
Neutrophil-lymphocyte ratio and red blood cell distribution width in patients with atrial fibrillation and rheumatic valve disease. Current vascular pharmacology (2023)
Pinelopi Triantafyllidou, Anna Papadopoulou, Eirini Thymara, Vassiliki Papaevangelou, George Mastorakos, Anastasios Papadimitriou, Sophia Kalantaridou, Constanine A Stratakis, Efthymia Alexopoulou
Aortic Intima-Media Thickness is Increased in Neonates of Mothers with Gestational Diabetes Mellitus: The Role of Thioredoxin-Interacting Protein as a Marker of Oxidative Stress. Current vascular pharmacology (2023)
Tolga Demir, Mazlum Sahin, Fatma Tugba Ilal Mert, Fatma Sarac
Effects of Cilostazol on the Myocardium in an Obese Wistar Rat Model of Ischemia-Reperfusion Injury. Current vascular pharmacology (2023)
Antonis A Manolis, Theodora A Manolis, Helen Melita, Antonis S Manolis
Features of a Balanced Healthy Diet With Cardiovascular and Other Benefits. Current vascular pharmacology (2023)

volume 21, number 3, 2023

Dimitris Benas, Helen Triantafyllidi, Dionyssia Birmpa, Anastasia Fambri, Antonios Schoinas, Ioannis Thymis, Gavriela Kostelli, Ignatios Ikonomidis
Hypertension-Mediated Organ Damage In Young Patients With First-Diagnosed And Never Treated Systolic Hypertension. Current vascular pharmacology 21 (3) (2023)